Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hadam

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|July 1, 1988
Establishment and characterization of a permanent human IgA2/kappa myeloma cell lineJ Lohmeyer, M Hadam, S Santoso, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1984
Analysis of mast cells in rheumatoid arthritis and osteoarthritis by an avidin-peroxidase stainingP Fritz, H Reiser, J G Saal, et al.
Immunobiology|February 1, 1989
Predominant immunoglobulin gene rearrangements in two patients with immunodeficiency: restricted use of V gene segments and DNA hypermethylationG Hauke, M Hadam, J T Epplen, et al.
European Journal of Cell Biology|April 1, 1989
TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigensR Hass, H Bartels, N Topley, et al.
Immunobiology|April 1, 1985
Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodiesC Müller, A Ziegler, C Muller, et al.
Molecular Biotherapy|June 1, 1991
Diminished expression of interleukin-2 receptors in vivo after prior chemotherapy in advanced cancer patients receiving recombinant interleukin-2J Atzpodien, A Körfer, M Hadam, et al.
Molecular Biotherapy|June 1, 1992
Biologic and therapeutic efficacy of mafosfamide in patients with metastatic renal cell carcinomaA Schomburg, T Menzel, M Hadam, et al.
European Journal of Pediatrics|April 1, 1989
Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemiaD J Byrd, H P Krohn, L Winkler, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responsesU Zorn, S Duensing, F Langkopf, et al.
Molecular Biotherapy|December 1, 1992
Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alphaS Duensing, M Hadam, A Körfer, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|July 1, 1988
Establishment and characterization of a permanent human IgA2/kappa myeloma cell lineJ Lohmeyer, M Hadam, S Santoso, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1984
Analysis of mast cells in rheumatoid arthritis and osteoarthritis by an avidin-peroxidase stainingP Fritz, H Reiser, J G Saal, et al.
Immunobiology|February 1, 1989
Predominant immunoglobulin gene rearrangements in two patients with immunodeficiency: restricted use of V gene segments and DNA hypermethylationG Hauke, M Hadam, J T Epplen, et al.
European Journal of Cell Biology|April 1, 1989
TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigensR Hass, H Bartels, N Topley, et al.
Immunobiology|April 1, 1985
Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodiesC Müller, A Ziegler, C Muller, et al.
Molecular Biotherapy|June 1, 1991
Diminished expression of interleukin-2 receptors in vivo after prior chemotherapy in advanced cancer patients receiving recombinant interleukin-2J Atzpodien, A Körfer, M Hadam, et al.
Molecular Biotherapy|June 1, 1992
Biologic and therapeutic efficacy of mafosfamide in patients with metastatic renal cell carcinomaA Schomburg, T Menzel, M Hadam, et al.
European Journal of Pediatrics|April 1, 1989
Neonatal pyruvate dehydrogenase deficiency with lipoate responsive lactic acidaemia and hyperammonaemiaD J Byrd, H P Krohn, L Winkler, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responsesU Zorn, S Duensing, F Langkopf, et al.
Molecular Biotherapy|December 1, 1992
Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alphaS Duensing, M Hadam, A Körfer, et al.
Pageof 3